The known burden of Huntington disease in the North of Scotland: prevalence of manifest and identified pre-symptomatic gene expansion carriers in the molecular era

BACKGROUND: Huntington disease prevalence was first estimated in Grampian, northern Scotland in 1984. Molecular testing has since increased ascertainment. OBJECTIVE: To estimate the prevalence of manifest Huntington disease and identified pre-symptomatic gene expansion carriers (IPGEC) in northern S...

Descripción completa

Detalles Bibliográficos
Autores principales: Kounidas, Georgios, Cruickshank, Heather, Kastora, Stavroula, Sihlabela, Stella, Miedzybrodzka, Zosia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505295/
https://www.ncbi.nlm.nih.gov/pubmed/33856548
http://dx.doi.org/10.1007/s00415-021-10505-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505295/
https://www.ncbi.nlm.nih.gov/pubmed/33856548
http://dx.doi.org/10.1007/s00415-021-10505-w

Ejemplares similares